Method For Detecting Shilling Attacks In E-commerce Systems Using Weighted Temporal Rules

The problem of shilling attacks detecting in e-commerce systems is considered. The purpose of such attacks is to artificially change the rating of individual goods or services by users in order to increase their sales. A method for detecting shilling attacks based on a comparison of weighted temporal rules for the processes of selecting objects with explicit and implicit feedback from users is proposed. Implicit dependencies are specified through the purchase of goods and services. Explicit feedback is formed through the ratings of these products. The temporal rules are used to describe hidden relationships between the choices of user groups at two consecutive time intervals. The method includes the construction of temporal rules for explicit and implicit feedback, their comparison, as well as the formation of an ordered subset of temporal rules that capture potential shilling attacks. The method imposes restrictions on the input data on sales and ratings, which must be ordered by time or have timestamps. This method can be used in combination with other approaches to detecting shilling attacks. Integration of approaches allows to refine and supplement the existing attack patterns, taking into account the latest changes in user priorities

Management of an Advertising Campaign Based on the Model of the Enterprise's Logistic System

The study is devoted to solving the scientific problem of optimal expansion of the enterprise's market niche, taking into account potential demand and the formation of an effective advertising campaign. An economic-mathematical model of the enterprise's production activity has been developed taking into account logistics and market demand.The problem of determining the optimal advertising costs is solved in two formulations:a) the enterprise produces homogeneous goods and the wholesale warehouse can fulfill the retail order for any quantity of goods in the wholesale warehouse;b) the enterprise produces some products in assortment. In this case, a certain minimum stock of products should be available at the wholesale warehouse.The study found that the optimal advertising costs are determined by the value of all the main parameters of the enterprise's logistics system.This conclusion was obtained as a result of careful model accounting of the structure of the enterprise's logistics system. All the main links (flows) between the elements of the logistics system were also taken into account. The simulation was performed in such a way that non-physical phenomena (for example, storage overflow, etc.) did not appear at the intermediate stages of modeling. The calculations found that with the planned capacity of 4.1 (units per day), the annual profit will be 3975.5 (units) with an optimal advertising cost of 44.8 (units). The practical significance of the study is that scientific ideas about the relationship of the advertising campaign with the production potential of the enterprise can serve as the basis for more efficient management of the budget process at the enterprise, namely: more informed planning of production volumes and expenses for its advertising campaig

A Survey of Empirical Results on Program Slicing

International audienceBACKGROUND:Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these complications.METHODS:This was a multicentre, double-blind, randomised placebo-controlled trial for which patients were recruited at 602 hospitals, clinics, or community practices from 33 countries across six continents. Eligible patients had a history of peripheral artery disease of the lower extremities (previous peripheral bypass surgery or angioplasty, limb or foot amputation, intermittent claudication with objective evidence of peripheral artery disease), of the carotid arteries (previous carotid artery revascularisation or asymptomatic carotid artery stenosis of at least 50%), or coronary artery disease with an ankle-brachial index of less than 0·90. After a 30-day run-in period, patients were randomly assigned (1:1:1) to receive oral rivaroxaban (2·5 mg twice a day) plus aspirin (100 mg once a day), rivaroxaban twice a day (5 mg with aspirin placebo once a day), or to aspirin once a day (100 mg and rivaroxaban placebo twice a day). Randomisation was computer generated. Each treatment group was double dummy, and the patient, investigators, and central study staff were masked to treatment allocation. The primary outcome was cardiovascular death, myocardial infarction or stroke; the primary peripheral artery disease outcome was major adverse limb events including major amputation. This trial is registered with ClinicalTrials.gov, number NCT01776424, and is closed to new participants.FINDINGS:Between March 12, 2013, and May 10, 2016, we enrolled 7470 patients with peripheral artery disease from 558 centres. The combination of rivaroxaban plus aspirin compared with aspirin alone reduced the composite endpoint of cardiovascular death, myocardial infarction, or stroke (126 [5%] of 2492 vs 174 [7%] of 2504; hazard ratio [HR] 0·72, 95% CI 0·57-0·90, p=0·0047), and major adverse limb events including major amputation (32 [1%] vs 60 [2%]; HR 0·54 95% CI 0·35-0·82, p=0·0037). Rivaroxaban 5 mg twice a day compared with aspirin alone did not significantly reduce the composite endpoint (149 [6%] of 2474 vs 174 [7%] of 2504; HR 0·86, 95% CI 0·69-1·08, p=0·19), but reduced major adverse limb events including major amputation (40 [2%] vs 60 [2%]; HR 0·67, 95% CI 0·45-1·00, p=0·05). The median duration of treatment was 21 months. The use of the rivaroxaban plus aspirin combination increased major bleeding compared with the aspirin alone group (77 [3%] of 2492 vs 48 [2%] of 2504; HR 1·61, 95% CI 1·12-2·31, p=0·0089), which was mainly gastrointestinal. Similarly, major bleeding occurred in 79 (3%) of 2474 patients with rivaroxaban 5 mg, and in 48 (2%) of 2504 in the aspirin alone group (HR 1·68, 95% CI 1·17-2·40; p=0·0043).INTERPRETATION:Low-dose rivaroxaban taken twice a day plus aspirin once a day reduced major adverse cardiovascular and limb events when compared with aspirin alone. Although major bleeding was increased, fatal or critical organ bleeding was not. This combination therapy represents an important advance in the management of patients with peripheral artery disease. Rivaroxaban alone did not significantly reduce major adverse cardiovascular events compared with asprin alone, but reduced major adverse limb events and increased major bleeding